Tech Company Financing Transactions

Ocera Therapeutics Funding Round

Greenspring Global Partners, CDIB Bioscience and Cross Creek Capital invested in a $35.5 million Series C funding round for Ocera Therapeutics. This venture round was announced on 2/20/2008.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

525 University Avenue 610
Palo Alto, CA 94301
USA

Phone

(650) 475-0158

Website

www.ocerainc.com

Email Address

[email protected]

Overview

Ocera Therapeutics Inc. founded in January 2005, is a privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for gastrointestinal and liver diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Linda Grais

        

Chief Financial Officer

Michael Byrnes

        

VP - Sales

Gaurav Aggarwal

        

Browse more venture capital transactions:

Prev: 2/20/2008: Bleacher Report venture capital transaction
Next: 2/20/2008: Incipient venture capital transaction

Share this article

About Our VC Transactions Data

We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary